Literature DB >> 9442143

Acetabulum malignancies: technique and impact on pain of percutaneous injection of acrylic surgical cement.

A Weill1, H Kobaiter, J Chiras.   

Abstract

The aim of our study was to describe the technique of percutaneous injection of acrylic surgical cement into acetabulum malignancies [percutaneous acetabuloplasty (PCA)] and determine its efficiency in relieving pain. Eighteen patients (8 men, 10 women; aged 40-81 years) with painful acetabular malignancies (18 lesions; 17 metastases, 1 multifocal bone sarcoma) were treated with PCA. Procedures were done using lateral approach with fluoroscopic guidance. The 18 procedures were evaluated and resulted in 4 (22 %) total improvement, 7 (39 %) clear improvement, 4 (22 %) moderate improvement, 1 (6 %) no improvement, and 2 (11 %) worsening in keeping with a cement leak in contact with the sciatic nerve and a leak towards the joint. Follow-up ranged from 2 to 48 months (average 9.4 months). We observed 2 cases of recurrence of pain at 6 and 39 months, both in keeping with local tumoral progression. PCA of malignancies is a minimally invasive and low-cost procedure that provides immediate and long-term pain relief.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442143     DOI: 10.1007/s003300050351

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

Review 1.  Interventional MSK procedures: the hip.

Authors:  Emilie Dodré; Guillaume Lefebvre; Eric Cockenpot; Patrick Chastanet; Anne Cotten
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

Review 2.  Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem.

Authors:  Matthew R Callstrom; J William Charboneau; Matthew P Goetz; Joseph Rubin; Thomas D Atwell; Michael A Farrell; Timothy J Welch; Timothy P Maus
Journal:  Skeletal Radiol       Date:  2005-10-05       Impact factor: 2.199

3.  Cementoplasty of pelvic bone metastases: systematic assessment of lesion filling and other factors that could affect the clinical outcomes.

Authors:  Thomas P Moser; Marta Onate; Katia Achour; Véronique Freire
Journal:  Skeletal Radiol       Date:  2019-02-02       Impact factor: 2.199

4.  Percutaneous sacroplasty for hemorrhagic metastases from hepatocellular carcinoma.

Authors:  Akihiro Uemura; Masaki Matsusako; Yuji Numaguchi; Masaki Oka; Nobuo Kobayashi; Chikako Niinami; Tomonori Kawasaki; Koyu Suzuki
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

5.  Treatment of symptomatic para-articular intraosseous cysts by percutaneous injection of bone cement.

Authors:  Boris Maurel; Thomas Le Corroller; Guillaume Bierry; Xavier Buy; Philippe Host; Afshin Gangi
Journal:  Skeletal Radiol       Date:  2012-04-17       Impact factor: 2.199

6.  Percutaneous osteoplasty for painful sternal lesion from multiple myeloma.

Authors:  Bing Zhou; Chun-Gen Wu; Ming-Hua Li; Yi-Feng Gu; Yong-De Cheng
Journal:  Skeletal Radiol       Date:  2008-12-03       Impact factor: 2.199

7.  Percutaneous osteoplasty for the management of a femoral head metastasis: a case report.

Authors:  Wei-Guo Wang; Chun-Gen Wu; Yi-Feng Gu; Ming-Hua Li
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

8.  A single-dose conformal delivery of radiotherapy following osteoplasty : a novel approach to treatment of osteolytic metastasis in the setting of multiple myeloma.

Authors:  A Gabriella Wernicke; Albert Sabbas; Fridon Kulidzhanov; Michael Shamis; Yevgeniya Golster; Ruben Niesvizky; Joseph Lane
Journal:  HSS J       Date:  2011-12-17

9.  Combination acetabular radiofrequency ablation and cementoplasty using a navigational radiofrequency ablation device and ultrahigh viscosity cement: technical note.

Authors:  Adam N Wallace; Ambrose J Huang; Devin Vaswani; Randy O Chang; Jack W Jennings
Journal:  Skeletal Radiol       Date:  2015-09-26       Impact factor: 2.199

Review 10.  Analgesia for patients with advanced disease: I.

Authors:  E J Hall; N P Sykes
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.